The CRC Asia-Pacific Market Will Be Valued at $7.9 Billion in 2023, Growing from $4.7 Billion in 2016 at a CAGR of 7.9%
Colorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. There were more than 1.4 million newly diagnosed CRC cases in 2012, accounting for 9.7% of the total number of cancer cases. This figure has been gradually rising in the Asia-Pacific region, with the growing elderly population and increasingly Westernized lifestyles.
View full press release